This Article Full Text Full Text (PDF) All Versions of this Article: 120/3/190    most recent CIRCULATIONAHA.109.876607v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Hess, D. T. Articles by Stamler, J. S. PubMed PubMed Citation Articles by Hess, D. T. Articles by Stamler, J. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Biochemistry and metabolism Other heart failure Acute myocardial infarction Oxidant stress Receptor pharmacology Endothelium/vascular type/nitric oxide Related Article

(Circulation. 2009;120:190-193.)
© 2009 American Heart Association, Inc.

Editorial

Assays for S-Nitrosothiols and S-Nitrosylated Proteins and Mechanistic Insights Into Cardioprotection

Douglas T. Hess, PhD; Matthew W. Foster, PhD; Jonathan S. Stamler, MD

From the Departments of Medicine (D.T.H., M.W.F., J.S.S.) and Biochemistry (J.S.S.), Duke University Medical Center, Durham, NC.

Correspondence to Dr Jonathan S. Stamler, Department of Medicine, Box 2612, Duke University Medical Center, Durham, NC 27710. E-mail staml001@mc.duke.edu

Key Words: Editorials • cardiomyopathy • endothelium-derived factors • hypoxia • myocardial infarction • nitric oxide

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Gender differences in the incidence of cardiovascular disease may be ascribed at least in part to the protective effects of estrogen through both long-term and rapid ("nongenomic") actions.¹ Nitric oxide (NO), generated by endogenous cardiac NO synthases (NOS; NOS1 or neuronal NOS [nNOS], NOS2 or inducible NOS, NOS3 or endothelial NOS), plays a major role in both normal cardiac physiology and cardioprotection (particularly myocardial ischemia/reperfusion injury; see the Figure),² and the article by Lin et al³ in this issue of Circulation contributes to growing evidence that the cardioprotective functions of estrogen are conveyed in significant part by NO. A rapidly expanding body of studies indicates that NO acts in most cellular contexts largely through the covalent modification of protein Cys thiols (to generate an S-nitroso [SNO]-protein, designated S-nitrosylation),⁴ and recent analyses using a new generation of analytical approaches (see the Table) both confirm original measurements of SNO-proteins that have been long-standing sources of controversy in the field and point to important roles for S-nitrosylation in NO-derived cardioprotection (see the Figure).^3,5,6

View larger version (13K):   Figure. NO-based mechanisms for preconditioning in ischemia/reperfusion injury. Accumulating evidence suggests a role for NO/SNO in estrogen and adrenergic receptor–mediated and statin-induced preconditioning in ischemia/reperfusion injury. Protein S-nitrosylation, resulting from increased NOS expression and activity and altered subcellular localization, appears to be a principal mediator of these effects.

View this table:   Table. Methodologies for the Detection and Absolute or Relative Quantification of SNO-Proteins and Other S-Nitrosothiols

Article see p 245

In the myocardium, endothelial NOS . . . [Full Text of this Article]

Related Article:

Estrogen Receptor-β Activation Results in S-Nitrosylation of Proteins Involved in Cardioprotection

Jeffrey Lin, Charles Steenbergen, Elizabeth Murphy, and Junhui Sun
Circulation 2009 120: 245-254. [Abstract] [Full Text]